Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer
by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-
Updated on: September 27,2024
0

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer
by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-
Updated on:September 27,2024
0
